CLINICAL_TRIALS
trial_result
· 2024-02-09
Clinical Trial Update: A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque Psoriasis [Phase 3]
Summary
Phase 3 trial comparing ABP 501 with Humira in moderate to severe plaque psoriasis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Plaque Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2024-02-09